- Home
- ATYR vs ONEW Comparison
ATYR vs ONEW Comparison
Compare ATYR & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- ONEW
- Stock Information
- Founded
- ATYR 2005
- ONEW 2014
- Country
- ATYR United States
- ONEW United States
- Employees
- ATYR N/A
- ONEW N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- ONEW Auto & Home Supply Stores
- Sector
- ATYR Health Care
- ONEW Consumer Discretionary
- Exchange
- ATYR Nasdaq
- ONEW Nasdaq
- Market Cap
- ATYR 330.7M
- ONEW 318.6M
- IPO Year
- ATYR 2015
- ONEW 2020
- Fundamental
- Price
- ATYR $3.68
- ONEW $17.26
- Analyst Decision
- ATYR Strong Buy
- ONEW Buy
- Analyst Count
- ATYR 6
- ONEW 5
- Target Price
- ATYR $18.60
- ONEW $23.75
- AVG Volume (30 Days)
- ATYR 1.9M
- ONEW 137.1K
- Earning Date
- ATYR 03-13-2025
- ONEW 05-01-2025
- Dividend Yield
- ATYR N/A
- ONEW N/A
- EPS Growth
- ATYR N/A
- ONEW N/A
- EPS
- ATYR N/A
- ONEW N/A
- Revenue
- ATYR $235,000.00
- ONEW $1,784,431,000.00
- Revenue This Year
- ATYR $1,387.23
- ONEW $5.21
- Revenue Next Year
- ATYR $873.22
- ONEW $4.08
- P/E Ratio
- ATYR N/A
- ONEW N/A
- Revenue Growth
- ATYR N/A
- ONEW N/A
- 52 Week Low
- ATYR $1.42
- ONEW $14.13
- 52 Week High
- ATYR $4.66
- ONEW $31.36
- Technical
- Relative Strength Index (RSI)
- ATYR 50.20
- ONEW 51.66
- Support Level
- ATYR $2.98
- ONEW $15.96
- Resistance Level
- ATYR $4.32
- ONEW $17.62
- Average True Range (ATR)
- ATYR 0.36
- ONEW 1.12
- MACD
- ATYR 0.03
- ONEW 0.13
- Stochastic Oscillator
- ATYR 60.37
- ONEW 89.68
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segment- Dealerships and Distribution. Its dealer groups are located throughout the Southeast, Gulf Coast, Mid-Atlantic, and Northeast. The company's revenue profile is comprised of new boat sales, pre-owned boat sales, finance and insurance products, repair and maintenance services, and parts and accessories. Majority of revenue is generated from sale of new boats.